Who invested in Reunion Neuroscience?

3 investors are on record as having backed Reunion Neuroscience — lead asset is a fast-acting and durable antidepressant for postpartum, in Biotech. Each row below says whether the round came from the investor's own portfolio page or from the press.

images.squarespace-cdn.com/content/v1/602d56549578a855471d8249/1613591674541-IT3SSDY4215G84LSJJTB/favicon.ico?format=100w

Reunion Neuroscience investors

1 more investors on record for Reunion Neuroscience.

The first two are open to everyone. A free account opens the rest — the fund, the round, the amount and where each number came from. No card, no demo call.

Create a free account

No round dates are on record for Reunion Neuroscience. A portfolio page names its companies far more often than it dates the cheque, and we would rather leave the field empty than guess it.

The funds that backed Reunion Neuroscience are in the directory.

If they wrote this cheque, they may write yours. Pitch2Fund scores your startup against every one of them, gives you the partner to write to, and drafts the email. Free.